Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.
Inge MickJim MyersAnna C RamosPaul R A StokesDavid ErritzoeAlessandro ColasantiRoger N GunnEugenii A RabinerGraham E SearleAdam D WaldmanMark C ParkinAlan D BrailsfordJosé C F GaldurózHenrietta Bowden-JonesLuke ClarkDavid J NuttAnne R Lingford-HughesPublished in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2015)
Pathological gambling is a psychiatric disorder and the first recognized behavioral addiction, with similarities to substance use disorders but without the confounding effects of drug-related brain changes. Pathophysiology within the opioid receptor system is increasingly recognized in substance dependence, with higher mu-opioid receptor (MOR) availability reported in alcohol, cocaine and opiate addiction. Impulsivity, a risk factor across the addictions, has also been found to be associated with higher MOR availability. The aim of this study was to characterize baseline MOR availability and endogenous opioid release in pathological gamblers (PG) using [(11)C]carfentanil PET with an oral amphetamine challenge. Fourteen PG and 15 healthy volunteers (HV) underwent two [(11)C]carfentanil PET scans, before and after an oral administration of 0.5 mg/kg of d-amphetamine. The change in [(11)C]carfentanil binding between baseline and post-amphetamine scans (ΔBPND) was assessed in 10 regions of interest (ROI). MOR availability did not differ between PG and HV groups. As seen previously, oral amphetamine challenge led to significant reductions in [(11)C]carfentanil BPND in 8/10 ROI in HV. PG demonstrated significant blunting of opioid release compared with HV. PG also showed blunted amphetamine-induced euphoria and alertness compared with HV. Exploratory analysis revealed that impulsivity positively correlated with caudate baseline BPND in PG only. This study provides the first evidence of blunted endogenous opioid release in PG. Our findings are consistent with growing evidence that dysregulation of endogenous opioids may have an important role in the pathophysiology of addictions.
Keyphrases
- chronic pain
- pain management
- computed tomography
- risk factors
- mental health
- magnetic resonance imaging
- positron emission tomography
- pet ct
- magnetic resonance
- multiple sclerosis
- resting state
- oxidative stress
- functional connectivity
- brain injury
- diabetic rats
- pet imaging
- subarachnoid hemorrhage
- blood brain barrier
- contrast enhanced
- data analysis